Choices for pharmacologic therapy should be guided by a 10-year global risk assessment score for ASCVD or coronary heart disease using established risk equations (eg, the Framingham risk calculator, ...

The 2026 American dyslipidemia guideline now endorses the PREVENT equations to guide lipid-lowering therapy in primary prevention in adults. Lipid-lowering therapy can be considered with a 10-year ...

Treatment for elevated blood lipid levels should begin much earlier and more aggressively to reduce the risk for atherosclerotic cardiovascular disease (ASCVD), according to an updated comprehensive ...

Despite advancements in treatment and prevention, patients with established atherosclerotic cardiovascular disease (ASCVD) still have a particularly high risk of having another heart attack, stroke, ...

—Recent studies suggest that a hospitalization related to cardiovascular events can follow a hospitalization for chronic obstructive pulmonary disease. But have these studies been too broad? No ...

Women with uterine fibroids, compared with those without the benign gynecological tumors, have a greater risk of developing atherosclerotic cardiovascular disease (ASCVD) up to 10 years down the line, ...

Please provide your email address to receive an email when new articles are posted on . Risk for heart disease was increased in people with a coronary artery calcium score of more than 0 and elevated ...